BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 3106405)

  • 1. Results of planned in-vitro fertilization programming through the pre-administration of the oestrogen-progesterone combined pill.
    Cohen J; Debache C; Solal P; Serkine AM; Achard B; Boujenah A; Pez JP; Paris X; Robert J; Loffredo V
    Hum Reprod; 1987 Jan; 2(1):7-9. PubMed ID: 3106405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Programmed oocyte retrieval: clinical and biological effects of oral contraceptives administered before in vitro fertilization.
    Mashiach S; Dor J; Goldenberg M; Shalev J; Levran D; Rudak E; Nebel L; Goldman B; Blankstein J; Ben-Rafael Z
    Gynecol Endocrinol; 1989 Jun; 3(2):107-15. PubMed ID: 2816477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimal stimulation IVF using clomiphene citrate and oral contraceptive pill pretreatment for LH suppression.
    Branigan EF; Estes MA
    Fertil Steril; 2000 Mar; 73(3):587-90. PubMed ID: 10689017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of fertility with oral medication.
    Diddle AW; Watts GF; Gardner WH; Williamson PJ
    West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
    Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P
    Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does anovulation induced by oral contraceptives favor pregnancy during the following two menstrual cycles?
    Fukuda M; Fukuda K; Yding Andersen C; Byskov AG
    Fertil Steril; 2000 Apr; 73(4):742-7. PubMed ID: 10731535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential regimen of the antiprogesterone RU486 and synthetic progestin for contraception.
    Kekkonen R; Lähteenmäki P; Luukkainen T; Tuominen J
    Fertil Steril; 1993 Oct; 60(4):610-5. PubMed ID: 8405512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy, bleeding patterns, and side effects of a 1-year contraceptive vaginal ring.
    Weisberg E; Fraser IS; Lacarra M; Mishell DR; Alvarez F; Brache V; Nash HA
    Contraception; 1999 May; 59(5):311-8. PubMed ID: 10494485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some aspects of studies with oral contraceptives in Indian women.
    Shah PN
    J Obstet Gynaecol India; 1966 Aug; 16(4):409-14. PubMed ID: 12262163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the combined steroidal contraceptives (Gynanovlar 21 and Lyndiol 2.5) on the human adrenocortical and ovarian activities.
    Zaki K; Kamal I; Talaat MM; Rashad S; Nour H
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):41-65. PubMed ID: 12256027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of injectable norethisterone oenanthate on ovarian hormones in Thai women.
    Werawatgoompa S; Vaivanijkul B; Leepipatpaiboon S; Channiyom K; Virutamasen P; Dusitsin N
    Contraception; 1980 Mar; 21(3):299-309. PubMed ID: 7389353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaginal administration of a combined oral contraceptive containing norethisterone acetate.
    Souka AR; Kamel M; Einen MA; Saleh F; Sallam H
    Contraception; 1985 Jun; 31(6):571-81. PubMed ID: 3899504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaginal bleeding patterns among women using one natural and eight hormonal methods of contraception.
    Belsey EM
    Contraception; 1988 Aug; 38(2):181-206. PubMed ID: 2971505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment with an oral contraceptive is effective in reducing the incidence of functional ovarian cyst formation during pituitary suppression by gonadotropin-releasing hormone analogues.
    Biljan MM; Mahutte NG; Dean N; Hemmings R; Bissonnette F; Tan SL
    J Assist Reprod Genet; 1998 Nov; 15(10):599-604. PubMed ID: 9866068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on ovarian function in users of the progestagen only contraceptive pill.
    Tayob Y; Guillebaud J; Adams J; Jacobs HS
    J Obstet Gynaecol (Lahore); 1986 Apr; 6 Suppl 2():S91-5. PubMed ID: 12315277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and biological justifications for the use of Triella].
    McGuire JL; Pasquale SA; Castaigne JP
    Rev Fr Gynecol Obstet; 1986 Dec; 81(12):731-6. PubMed ID: 3823727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid function tests under the effect of steroidal contraceptives compared to normal pregnancy.
    Nasr EM; El-mekkawi T; Abbas A; El-sheikha Z; Abdel Aziz A
    Popul Sci; 1982; (3):157-68. PubMed ID: 12266214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Return of ovulation and fertility in women using norethisterone oenanthate.
    Fotherby K; Yong-En S; Howard G; Elder MG; Muggeridge J
    Contraception; 1984 May; 29(5):447-55. PubMed ID: 6744861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol.
    Carlström K; Lunell NO; Zador G
    Gynecol Obstet Invest; 1978; 9(6):304-11. PubMed ID: 754992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term gonadotropin suppression with oral contraceptives benefits poor responders prior to controlled ovarian hyperstimulation.
    Lindheim SR; Barad DH; Witt B; Ditkoff E; Sauer MV
    J Assist Reprod Genet; 1996 Oct; 13(9):745-7. PubMed ID: 8947826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.